Four-year legal battle over mifepristone traces shifting judicial landscape
Four years of legal battles show shifting judicial treatment of mifepristone access despite Supreme Court precedent.
02 / Read
Beyond the headline.
Start with the essentials. Stay for the perspective.
The reading room
2 alternative perspectives
Trump administration intensifies mifepristone enforcement through cabinet appointments
Trump administration shifts mifepristone enforcement through cabinet appointments and new safety reviews.
Federal court suspends mifepristone mail delivery as restrictions expand
Federal appeals court blocks mifepristone mailing nationwide as Louisiana pursues expanded restrictions.
Spirit Airlines completes final operations, begins automated refund process
Spirit Airlines completes shutdown after 34 years; fuel costs and failed bailout cited; automatic refunds pledged.
NBA fines Robinson $50K, Daniels $25K for playoff altercation
NBA fined Robinson $50K and Daniels $25K for their playoff altercation.
Knicks cruise to dominant Game 6 victory over Hawks
Knicks defeated Hawks 140-89 in Game 6, winning by 51 points.
Pistons erase 24-point deficit to force Game 7 against Magic
Pistons erase 24-point deficit to force Game 7 as Cunningham scores 32 in historic Magic collapse.
Trump administration escalates military actions across Latin America and Iran
Trump administration removes Maduro, eliminates Khamenei, signals Iran conflict nearing end.
Trump declares US will take over Cuba almost immediately
Trump declares US takeover of Cuba almost immediately, referencing prior policy statements.
Domino's driver arrested after striking customer with vehicle over tip dispute
Domino's driver charged with first-degree assault after striking customer with vehicle over tip dispute.
Mifepristone access narrows as courts and regulators tighten restrictions
Court blocks mifepristone mailing; federal reviews threaten access to medication used in most U.S. abortions.
Regulatory uncertainty clouds mifepristone's future as review timelines extend
Multiple regulatory reviews and court restrictions create uncertainty over mifepristone's approved status.